Insight

Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus

Photo from Erman Akkus/X

Aug 17, 2024, 19:56

Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus

Erman Akkus, Medical Oncology Fellow a post on X:

“Oncotype DX Colon Recurrence Score in stage II colon cancer at ESMO Open.

Real-word data, 938 patients
Higher score ->worse clinicopathologial factors, higher treatment
Score is prognostic
In high score (41-100), ChT vs observation, colon cancer specific survival, p=0.035“

Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data

Authors: B. Brenner, K. Shulman, A. Hubert, S. Man, R. Geva, I. Ben-Aharon, S. Fennig, M. Mishaeli, N. Yarom, G. Bar-Sela, R. Brenner, A. Shai, F.L. Baehner, C. Russell, L. Soussan-Gutman ,H. Voet, A. Bareket-Samish, and N. Liebermann.

Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus

Source: Erman Akkus/X

A. Bareket-Samish A. Hubert Ankara Üniversitesi Tıp Fakültesi B. Brenner cancer Colon cancer Erman Akkus ESMO Open H. Voet K. Shulman N. Liebermann OncoDaily Oncology

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage